Delivery Order SPE2DB24D2217-SPE2DB25FJVRR
Award Date
10/28/24
Potential Completion Date
10/29/24
Potential Value
$2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency (DLA) has awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a $3,930.60 firm fixed price delivery order contract for the supply of insulin degludec pens (U-200, 3ML). This delivery order is placed under an indefinite delivery contract (IDC) with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen Drug Corp to deliver...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,733.88 firm fixed price delivery order is for the procurement of Insulin Degludec Pen (U-200) 3ML, which is a specialty medication used for diabetes management.
The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of insulin degludec pens (U-200, 3 mL). The contract has a ceiling value of $4,417.19 and a completion date of January 2, 2025. It is a Firm Fixed Price Delivery Order with no set-aside designation, indicating open competition.
Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office division. The $1,710.72 firm fixed price contract is for the supply of insulin degludec pens (U-100, 3 mL) to support military treatment facilities and federal healthcare programs. The delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, which enables the DLA to efficiently...
This federal contract award is for the delivery of Insulin Degludec Pens (U-200) 3ML to the U.S. government. The $1,257.03 firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The contract has an ultimate completion date of August 29, 2024. Amerisourcebergen, a major pharmaceutical distributor, has been awarded numerous federal contracts to supply a wide range of essential medical...
This federal contract award to Amerisourcebergen Drug Corp is a Delivery Order valued at $1,313.56 for the supply of Insulin Degludec Pen (U-200) 3ML. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a major defense agency. This award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999, that enables the agency to efficiently procure a comprehensive range of pharmaceutical and medical...
This federal contract award, with the ID SPE2DB22D1202|SPE2DB25FUPB1, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,471.35 firm-fixed-price delivery order is for the supply of INSULIN DEGLUDEC PEN (U-200) 3ML, with a performance period ending on January 8, 2025. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a...
This is a delivery order award to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,395.72 firm fixed price contract is for the supply of Insulin Glargine-YFGN U100 Pen 3ML, a prescription insulin product. It is part of Amerisourcebergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at up to $999,999,999.00, which serves as the primary vehicle for the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,091.04 firm fixed-price delivery order is for the supply of insulin glargine-yfgn U100 pens. The contract has an ultimate completion date of November 25, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, which...
This federal contract award from the Defense Logistics Agency (DLA) was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on December 31, 2024. The $1,656.60 firm fixed-price delivery order is for the supply of Tresiba FlexTouch 200 unit/mL 3mL insulin pens. The award is not designated as a set-aside contract.
AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a wide range of pharmaceutical products...